Upgrade to SI Premium - Free Trial

Adaptive Biotechnologies (ADPT)

24.42 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/26)

Latest Headlines

Form 4 Adaptive Biotechnologies For: Oct 14 Filed by: RUBINSTEIN JULIE October 16, 2026 7:22 PM - SEC Filing Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 October 14, 2026 4:05 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Oct 09 Filed by: RUBINSTEIN JULIE October 13, 2026 7:06 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $32 at TD Cowen October 13, 2026 9:30 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $27 at Morgan Stanley October 13, 2026 8:22 AM - StreetInsider Form 4 Adaptive Biotechnologies For: Oct 06 Filed by: RUBINSTEIN JULIE October 8, 2026 6:55 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Oct 06 Filed by: BOBULSKY SUSAN October 8, 2026 6:53 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN October 6, 2026 4:23 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Oct 01 Filed by: RUBINSTEIN JULIE October 5, 2026 8:16 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Oct 01 Filed by: LO FRANCIS October 5, 2026 8:13 PM - SEC Filing Adaptogenics Appoints Accomplished Peptide Scientist Dr. J. David Warren as Chief Executive Officer October 2, 2026 7:31 AM - StreetInsider Form 144 Adaptive Biotechnologies Filed by: RUBINSTEIN JULIE October 1, 2026 4:33 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $32 at Guggenheim October 1, 2026 8:47 AM - StreetInsider Goldman Sachs Starts Adeptus Biotechnologies Corp. (ADPT) at Buy September 29, 2026 6:05 AM - StreetInsider Adaptogenics closes oversubscribed private placement raising $327,000 September 28, 2026 4:41 PM - StreetInsider Adaptogenics Health Corp. Announces Closing of Over Subscribed Non-Brokered Private Placement September 28, 2026 4:41 PM - StreetInsider Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure September 25, 2026 8:03 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG September 21, 2026 5:08 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Sep 16 Filed by: LO FRANCIS September 18, 2026 8:17 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Sep 15 Filed by: BOBULSKY SUSAN September 17, 2026 6:50 PM - SEC Filing NCCN updates myeloma guidelines, names clonoSEQ for MRD testing September 17, 2026 8:00 AM - StreetInsider Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ® September 17, 2026 8:00 AM - StreetInsider Form 144 Adaptive Biotechnologies Filed by: LO FRANCIS September 16, 2026 4:40 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN September 15, 2026 4:36 PM - SEC Filing Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference September 1, 2026 4:05 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Aug 26 Filed by: OWEN KATEY EINTERZ August 28, 2026 5:50 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: OWEN KATEY EINTERZ August 26, 2026 4:14 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 20, 2026 6:07 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 18 Filed by: HERSHBERG ROBERT August 20, 2026 5:56 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 17 Filed by: ROBINS CHAD M August 19, 2026 8:15 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 17 Filed by: NEUPERT PETER M August 19, 2026 8:08 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 19, 2026 6:28 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: HERSHBERG ROBERT August 18, 2026 6:18 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS CHAD M August 18, 2026 5:45 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 18, 2026 5:45 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 17, 2026 5:21 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS CHAD M August 17, 2026 5:21 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: NEUPERT PETER M August 17, 2026 4:49 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 10 Filed by: BOBULSKY SUSAN August 12, 2026 7:34 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN August 10, 2026 4:38 PM - SEC Filing Form 10-Q Adaptive Biotechnologies For: Jun 30 August 4, 2026 4:32 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $27.50 at Piper Sandler August 4, 2026 6:54 AM - StreetInsider Form 4 Adaptive Biotechnologies For: Jul 30 Filed by: BOBULSKY SUSAN August 3, 2026 6:27 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN July 30, 2026 4:38 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $28 at TD Cowen July 30, 2026 9:09 AM - StreetInsider Adaptive Biotechnologies Corp. (ADPT) PT Raised to $27 at JPMorgan July 30, 2026 8:57 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at Morgan Stanley July 30, 2026 8:13 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $25 at Guggenheim July 30, 2026 6:41 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $25 at BTIG July 30, 2026 5:10 AM - StreetInsider Adaptive Biotechnologies (ADPT) Misses Q2 EPS by 11c July 29, 2026 4:46 PM - StreetInsider Form 8-K Adaptive Biotechnologies For: Jul 24 July 29, 2026 4:15 PM - SEC Filing Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results July 29, 2026 4:05 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Jul 21 Filed by: ROBINS HARLAN S July 23, 2026 7:35 PM - SEC Filing Full Article List